SLC14A1: a novel target for human urothelial cancer
1Department of Urology, China Japan Union Hospital, Jilin University, Changchun, 130033, Jilin, China.
Abstract:
Urinary bladder cancer is the second commonly diagnosed genitourinary malignancy. Previously, bio-molecular alterations have been observed within certain locations such as chromosome 9, retinoblastoma gene and fibroblast growth factor receptor-3. Solute carrier family 14 member 1 (SLC14A1) gene encodes the type-B urea transporter (UT-B) which facilitates the passive movement of urea across cell membrane, and has recently been related with human malignancies, especially for bladder cancer. Herein, we discussed the SLC14A1 gene and UT-B protein properties, aiming to elucidate the expression behavior of SLC14A1 in human bladder cancer. Furthermore, by reviewing some well-established theories regarding the carcinogenesis of bladder cancer, including several genome wide association researches, we have bridged the mechanisms of cancer development with the aberrant expression of SLC14A1. In conclusion, the altered expression of SLC14A1 gene in human urothelial cancer may implicate its significance as a novel target for research.
Insights
The Solute carrier family 14 member 1 (SLC14A1) gene, encoding the UT-B protein, shows altered expression in bladder cancer. This finding suggests SLC14A1 may be a new research target for urothelial cancer.
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- Urinary bladder cancer is a prevalent genitourinary malignancy.
- Known alterations include chromosome 9, retinoblastoma gene, and FGFR3.
- Solute carrier family 14 member 1 (SLC14A1) gene, encoding the type-B urea transporter (UT-B), is implicated in malignancies.
Purpose of the Study:
- To discuss SLC14A1 gene and UT-B protein properties.
- To elucidate the expression behavior of SLC14A1 in human bladder cancer.
- To bridge cancer development mechanisms with aberrant SLC14A1 expression.
Main Methods:
- Literature review of established bladder cancer carcinogenesis theories.
- Analysis of genome-wide association studies.
- Discussion of SLC14A1 gene and UT-B protein properties.
Main Results:
- SLC14A1 gene and UT-B protein facilitate passive urea transport.
- Recent studies link SLC14A1 to human malignancies, particularly bladder cancer.
- Aberrant SLC14A1 expression is observed in human urothelial cancer.
Conclusions:
- Altered SLC14A1 expression in urothelial cancer warrants further investigation.
- SLC14A1 may represent a novel research target for bladder cancer.
- Understanding SLC14A1's role could advance bladder cancer research.
